Medicinal materials

Raw materials of plant, animal or mineral origin used for medicinal purposes — under Article 66 of the Pharmacy Law as amended by Law 44/2024/QH15, expressly including fungi. Distinct from processed traditional medicinal ingredients (processed traditional substances) and traditional medicines (finished traditional medicines). Quality is governed by Circular 32/2025/TT-BYT, which from 1 July 2025 requires the responsible establishment to publicly declare a quality standard before circulation. Cultivation/collection must meet GACP from 1 January 2030.

• Pharmacy Law Chapter VI + Law 44/2024/QH15.
• Circular 32/2025/TT-BYT (quality) + Circular 19/2019/TT-BYT (GACP).